Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or 鈥渓ot鈥� of Intravenous Immunoglobulin.
The global Intravenous Immunoglobulin (IVIg) market is projected to reach US$ 15470 million by 2030 from an estimated US$ 10970 million in 2024, at a CAGR of 5.9% during 2024 and 2030.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).
The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Immunoglobulin (IVIg) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
麻豆原创 Segmentation
By Company
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intravenous Immunoglobulin (IVIg) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Immunoglobulin (IVIg) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 麻豆原创 by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size Estimates and Forecasts
2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2019-2030
2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 2019-2030
2.2 Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Region: 2023 Versus 2030
2.3 Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2030)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2019-2024
2.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2025-2030)
2.3.3 Global Intravenous Immunoglobulin (IVIg) Sales 麻豆原创 Share by Region (2019-2030)
2.4 Intravenous Immunoglobulin (IVIg) 麻豆原创 Estimates and Projections by Region (2025-2030)
2.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2019-2024
2.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2025-2030)
2.4.3 Global Intravenous Immunoglobulin (IVIg) Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Intravenous Immunoglobulin (IVIg) by Manufacturers
3.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales
3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2019-2024)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 麻豆原创 Share by Manufacturer (2019-2024)
3.2 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2019-2024)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturer (2019-2024)
3.3 Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Intravenous Immunoglobulin (IVIg) Manufacturers Covered: Ranking by Revenue
3.4.2 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Product Type
3.5.1 Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
3.5.3 Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) 麻豆原创
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Baxter
4.1.1 Baxter Company Information
4.1.2 Baxter Description, Business Overview
4.1.3 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
4.1.4 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Baxter Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.1.6 Baxter Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.1.7 Baxter Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.1.8 Baxter Recent Developments
4.2 Grifols
4.2.1 Grifols Company Information
4.2.2 Grifols Description, Business Overview
4.2.3 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
4.2.4 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Grifols Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.2.6 Grifols Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.2.7 Grifols Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.2.8 Grifols Recent Developments
4.3 CSL
4.3.1 CSL Company Information
4.3.2 CSL Description, Business Overview
4.3.3 CSL Intravenous Immunoglobulin (IVIg) Products Offered
4.3.4 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.3.5 CSL Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.3.6 CSL Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.3.7 CSL Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.3.8 CSL Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Description, Business Overview
4.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
4.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Octapharma Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.4.6 Octapharma Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.4.7 Octapharma Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.4.8 Octapharma Recent Developments
4.5 Biotest
4.5.1 Biotest Company Information
4.5.2 Biotest Description, Business Overview
4.5.3 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
4.5.4 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Biotest Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.5.6 Biotest Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.5.7 Biotest Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.5.8 Biotest Recent Developments
4.6 Kedrion
4.6.1 Kedrion Company Information
4.6.2 Kedrion Description, Business Overview
4.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
4.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Kedrion Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.6.6 Kedrion Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.6.7 Kedrion Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.6.8 Kedrion Recent Development
4.7 Hualan Bio
4.7.1 Hualan Bio Company Information
4.7.2 Hualan Bio Description, Business Overview
4.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
4.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.7.6 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.7.7 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.7.8 Hualan Bio Recent Development
4.8 CNBG
4.8.1 CNBG Company Information
4.8.2 CNBG Description, Business Overview
4.8.3 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
4.8.4 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.8.5 CNBG Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.8.6 CNBG Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.8.7 CNBG Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.8.8 CNBG Recent Development
4.9 Shanghai RAAS
4.9.1 Shanghai RAAS Company Information
4.9.2 Shanghai RAAS Description, Business Overview
4.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
4.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.9.6 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.9.7 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.9.8 Shanghai RAAS Recent Development
4.10 CBPO
4.10.1 CBPO Company Information
4.10.2 CBPO Description, Business Overview
4.10.3 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
4.10.4 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.10.5 CBPO Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.10.6 CBPO Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.10.7 CBPO Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.10.8 CBPO Recent Development
4.11 LFB Group
4.11.1 LFB Group Company Information
4.11.2 LFB Group Description, Business Overview
4.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered
4.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.11.5 LFB Group Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.11.6 LFB Group Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.11.7 LFB Group Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.11.8 LFB Group Recent Development
4.12 BPL
4.12.1 BPL Company Information
4.12.2 BPL Description, Business Overview
4.12.3 BPL Intravenous Immunoglobulin (IVIg) Products Offered
4.12.4 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.12.5 BPL Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.12.6 BPL Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.12.7 BPL Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.12.8 BPL Recent Development
4.13 Sichuan Yuanda Shuyang
4.13.1 Sichuan Yuanda Shuyang Company Information
4.13.2 Sichuan Yuanda Shuyang Description, Business Overview
4.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered
4.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.13.5 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales by Product in 2023
4.13.6 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales by Application in 2023
4.13.7 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales by Geographic Area in 2023
4.13.8 Sichuan Yuanda Shuyang Recent Development
5 Breakdown Data by Type
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2025-2030)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales 麻豆原创 Share by Type (2019-2030)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2019-2030)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2024)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2025-2030)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue 麻豆原创 Share by Type (2019-2030)
5.3 Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030)
6.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)
6.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2025-2030)
6.1.3 Global Intravenous Immunoglobulin (IVIg) Sales 麻豆原创 Share by Application (2019-2030)
6.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2019-2030)
6.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2024)
6.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2025-2030)
6.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue 麻豆原创 Share by Application (2019-2030)
6.3 Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Intravenous Immunoglobulin (IVIg) 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures by Country
7.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
7.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
7.3 North America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)
7.4 North America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures by Region
8.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2030)
8.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2019-2030)
8.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)
8.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)
9 Europe
9.1 Europe Intravenous Immunoglobulin (IVIg) 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures by Country
9.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
9.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
9.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)
9.4 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Intravenous Immunoglobulin (IVIg) 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures by Country
10.2.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
10.2.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
10.3 Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)
10.4 Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures by Country
11.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
11.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
11.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)
11.4 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Intravenous Immunoglobulin (IVIg) Supply Chain Analysis
12.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials and Upstream Suppliers
12.3 Intravenous Immunoglobulin (IVIg) Clients Analysis
12.4 Intravenous Immunoglobulin (IVIg) Sales Channel and Sales Model Analysis
12.4.1 Intravenous Immunoglobulin (IVIg) Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Intravenous Immunoglobulin (IVIg) Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Intravenous Immunoglobulin (IVIg) Distributors
13 麻豆原创 Dynamics
13.1 Intravenous Immunoglobulin (IVIg) Industry Trends
13.2 Intravenous Immunoglobulin (IVIg) 麻豆原创 Drivers
13.3 Intravenous Immunoglobulin (IVIg) 麻豆原创 Challenges
13.4 Intravenous Immunoglobulin (IVIg) 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
听
听
*If Applicable.